Corporate Banner
Satellite Banner
Medicinal Chemistry
Scientific Community
 
Become a Member | Sign in
Home>Products>This Product
  Products


Rotavapor® R-210/R-215

Product Image
Product Description

The Rotavapors R-210/215 can be used for all kind of applications in different kind of laboratories. It not only combines maximum safety for the user but also for the product. The complete solution with vacuum controller, vacuum pump and recirculating chiller allows you to evaporate your solvents in the most efficient and gentle way.

The Rotavapor R-210/215 features the following advantages:

•    Maximum safety for the user and the product
•    Complete solution with vacuum controller, vacuum pump and recirculating chiller
•    Long-life seals provide practically maintenance-free operation and increase service life
•    A wide range of glass assemblies covers numerous applications
•    Compact assembly with small footprint
•    Wireless contacts on the heating bath for both power supply and communications
•    Proven BUCHI quality

Product Rotavapor® R-210/R-215
Company BUCHI Labortechnik AG
Price Request a quote
More Information View company product page
Catalog Number Unspecified
Quantity Unspecified
Company Logo

BUCHI Labortechnik AG
Meierseggstrasse 40 Postfach CH-9230 Flawil 1 Switzerland

Tel: +41 71 394 63 63
Fax: +41 71 394 64 64
Email: buchi@buchi.com



Scientific News
Accessing Metabolic Information with Mass Spec
Scientists at the Helmholtz Zentrum München have developed a new mass spectrometry imaging method which, for the first time, makes it possible to analyze hundreds of metabolites in fixed tissue samples.
Simplifying Gene Testing Access for Ovarian Cancer Patients
Simplifying access to gene testing for women with ovarian cancer improves treatment choices and could save lives.
New Protein Model Could Accelerate Drug Development
Stony Brook-led international research team creates ultra-fast approach to model protein interactions.
New Method Opens Door to Development of Many New Medicines
Findings from TSRI reveal human proteins are better drug targets than previously thought.
What Makes a Good Scientist?
It’s the journey, not just the destination that counts as a scientist when conducting research.
Angina Drug Could Inform A New Strategy To Fight Cryptococcosis
A drug, more commonly used in the treatment of angina, could be the focus of a new strategy in fighting the fatal fungal infection cryptococcosis.
New Skin Cancer Drugs with Surprising Powers
Inserm team synthesizes and developed new drugs for melanoma.
Breast Cancer Drug Hope
A drug for breast cancer that is more effective than existing medicines may be a step closer thanks to new research.
Benchtop Automation Trends
Gain a better understanding of current interest in and future deployment of benchtop automated systems.
A New Platform for Discovering Antibiotics
Harvard chemists hope to shorten time, difficulty in measuring their effectiveness, potential.

SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,900+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!